Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,282 total articles
Blue Owl Capital's BDC (OBDC) is trading at steep discount-to-book and high yield, but mounting credit fears, outsized short activity, and recent liquidity maneuvers create a tactical short opportunity. Entry $11.30, target $9.40, stop $12.10. Mid-term trade (45 trading days).
Synopsys is a high-quality EDA and IP franchise trading at premium multiples but with measurable de-risking catalysts: the Ansys deal, growing demand for software-defined product workflows (electronics digital twin), and solid free cash flow. This trade idea lays out an actionable long trade with entry, stop, and target levels tied to a 120-trading…
Novo Nordisk sits at the center of an increasingly binary GLP-1 fight. Eli Lilly's recent drug approvals and a stronger clinical edge for some pipeline assets increase the odds of market-share losses; Novo's valuation looks reasonable on paper but may not price in near-term revenue pressure. This trade idea proposes a mid-term short to capture furt…
Joby Aviation has the cash runway, regulatory progress and commercial partners that justify a constructive trade idea. The stock remains volatile and richly valued versus tiny revenue today, so this is a risk-on, event-driven trade: buy on market pullbacks around $8.79, target $14 on re-rating and early commercial revenue, stop at $6.50 to limit ca…
Volkswagen ADR (VWAGY) offers an asymmetric setup: a $53.7B market cap, single-digit P/E (7.0), and a 4.3% dividend yield priced into a stock that is bottoming technically. With positive MACD momentum, rising short interest that could fuel squeezes, and tangible progress on partnerships and software monetization, we prefer a tactical long. Entry, s…
Andy Jassy's shareholder letter read like a roadmap: aggressive AI and AWS expansion, disciplined retail cost cuts, and an eye toward margin recovery. Amazon's fundamentals and a market that underprices the optionality in AI infrastructure make a compelling near-term long trade. Entry $247.00, stop $230.00, target $300.00 over a long-term (180 trad…
Credo is executing into the AI connectivity upgrade cycle. The DustPhotonics acquisition, blistering revenue growth and strong margins remove the worst of the bear arguments. This is a tactical-to-position trade: enter on strength or small pullback, protect with a defined stop, and ride a re-rating as optical revenue and AEC momentum compound.
CME Group (CME) offers a rare combination for income-oriented investors: a high-quality exchange operator with $4.2B in free cash flow last year, a $7.45 per-share distribution that yields about 3.7% at current prices, and a business that benefits when markets get choppy. I like a position-sized, dividend-focused long at current levels with a clear…
Ituran is more than subscriber adds. With $107.6M in cash, no bank debt, recurring high-margin services and a sizable dividend program, the stock offers a tradeable asymmetric setup. I recommend a long with a defined entry, stop and target for a 180-trading-day horizon while watching margin expansion and capital allocation execution.
Capital One is a Buy on this pullback. The bank stands to benefit from a higher-rate environment, durable credit performance, and shareholder-friendly capital allocation. This trade idea lays out an entry at $95.00, a conservative stop at $82.00, and a primary target of $135.00 over a 180 trading day horizon, with clear catalysts and risk controls.
Apple remains uniquely positioned: a sticky ecosystem, recurring services revenue, and unmatched capital returns. Use a tactical swing entry after the recent pullback, with a defined stop and clear targets tied to improving sentiment and upcoming catalysts.
Tecnoglass (TGLS) trades at a modest EV/EBITDA of 8.2 and a P/E near 13, with a market cap of roughly $2.05B. Recent insider purchases and a sustained dividend raise the floor on the stock. We upgrade to Buy and propose a defined swing trade: entry $45.81, stop $41.00, target $58.00 over a mid-term 45-trading-day horizon.
CoreWeave sits at the nexus of GPU-driven AI demand and hyperscaler data-center spending. Recent multi-year deals with Meta and Anthropic, an enlarged $21B Meta expansion, and price increases give the company a clear runway for revenue and margin improvement. Valuation is rich for a loss-making operator, but for patient, risk-tolerant investors thi…
Snowflake (SNOW) is trading well below its 52-week highs after a sectorwide software selloff and fresh legal headlines. Fundamentals still support long-term demand for a modern data cloud, but valuation and momentum favor option sellers today. My trade: sell cash-secured puts in the mid-term (45 trading days) to collect premium and be paid to own t…
Bloom Energy rallied into a breakout after reports of a commercial agreement with Oracle that validates its positioning as a data-center power provider. The company shows rising revenue momentum and improving cash flow, but valuation remains rich (market cap ~$56.3B) and leverage is high. This trade idea is a tactical long with a clear entry at $20…
Rocket Lab's recent weakness looks like an overreaction. With a growing space-systems services business, steady small-sat launch demand and an upcoming Neutron program cadence that can re-rate sentiment, the current pullback offers a mid-term buying opportunity. Trade plan: enter $7.50, stop $5.75, target $12.00 with a 45-trading-day horizon.
Amazon looks set for a fresh re-rating if three new, concrete catalysts play out: a strategic shift in 2026 data-center spending, accelerating rollout of Amazon-designed AI silicon in AWS, and faster e-commerce automation that cuts fulfillment costs. Valuation at roughly $2.57T and a P/E ~33 already prices growth; this idea is a directional swing t…
Blue Owl (OWL) has been punished on private credit redemption headlines, but the firm's fee mix, strong free cash flow and a 52-week range that still leaves considerable upside argue for a tactical long. This trade idea outlines an entry, stop and target for a long-term recovery play and the key catalysts that would validate the thesis.
Patterson-UTI is positioned to benefit from a renewed run of U.S. and international drilling activity. With a market cap near $4.0B, attractive cash flow (FCF $372M), modest leverage, and a dividend yield north of 3%, PTEN offers a favorable risk/reward into what looks like the next drilling cycle leg up. Trade plan: enter $10.56, stop $8.75, targe…
Elbit Systems ($ESLT) is riding a clear war premium: a $28.1B backlog, fresh multi-hundred-million dollar contracts and accelerating ISTAR/EW revenue are boosting sentiment. But a $43.5B market cap, rich 82x PE and likely capacity limits on ramping production make this a tactical trade rather than a buy-and-forget idea. Enter on a modest pullback, …
Vistance Networks is no longer a balance-sheet cleanup story. After the divestiture of its Connectivity and Cable Solutions business and a planned $10+ per-share special distribution, the company emerges with retired debt, a cleaner portfolio of higher-growth networking and access solutions, and a valuation that appears undemanding. Technical momen…
Oneok (OKE) yields roughly 4.9% and benefits from higher energy prices tied to the Iran crisis, but 2026 guidance points to a growth pause while leverage is elevated and free cash flow is already largely committed to the dividend and projects. This trade idea takes a measured short stance over a mid-term horizon to capture mean reversion if fundame…
LVMUY has pulled back into what looks like a durable value zone after a sharp correction from its January highs. The business is diversified across resilient luxury categories, trades at a mid-20s P/E with a $273.7B market cap, and shows early technical signs of stabilized momentum. This trade plan targets a recovery toward the $130s over the next …
Spyre Therapeutics reported strong Part A induction results for SPY001 in ulcerative colitis (9.2-point Robarts histology improvement; 40% clinical remission; 51% endoscopic improvement), and is now enrolling Part B. The stock pulled back after a $300M common-share offering was announced, creating a tradeable setup. We favor a mid-term long (45 tra…
Commvault (CVLT) looks actionable on takeover speculation and supportive analyst momentum. Fundamentals show healthy cash flow and outsized ROE, while the float is compact and short interest remains meaningful. We upgrade to a Buy for a mid-term swing trade and lay out entry, stop and target.
